Navigation Links
India May not Face Bird Flu Outbreak

October 16, 2005: India may have escaped from the Bird Flu epidemic that is causing chaos in Turkey and Romania currently. It is known that migratory birds are carrying the viral strain H5N1//.

The migratory bird ‘Bar-headed geese’ usually migrate to India in winter and were affected by the deadly virus strain H5N1 that can kill human beings. So far the strain has killed 60 people due to the direct contact with affected and sick birds. This year the wild bird from China has decided to fly some other route and spare India from its destination.

“It looks as if India has escaped an outbreak this year because the migratory birds that visit India from China each year have gone to Turkey, Kazakhstan and Thailand. But the fear is very real and it’s just a matter of time,” said Dr Ranjit Roy Chaudhury of the National institute of Immunology.

Luckily the drug that works against the bird flu is called ‘Oseltamivir’ and is sold under the brandname ‘Tamiflu’ is available in India and is marketed by Roche pharma.

The question till recently was when was India likely to come into the ravage of Bird Flu and India went on high alert when thousands of migratory birds died of H5N1, the viral strain responsible for the current problem in the Qinghai lakeland in north-western China.

“Animal-to-human transmission cases are isolated and possible to isolate and treat. We have started stockpiling for such emergencies and are exploring the possibility of developing vaccines in India. In case of an epidemic, compulsory licensing is always an option, but it’s not needed now,” said Health minister Raadoss.
'"/>




Page: 1

Related medicine news :

1. Is Diabetes the Leading Cause of Kidney Failure in India
2. AIDS Disaster in India is Imminent
3. Indian Prime Minister has successful Knee Replacement Surgery
4. International community warns India on HIV situation
5. India takes on foot-and-mouth disease by vaccinating animals
6. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
7. India to benefit from pharma companies move
8. Healthcare sector is now a multi billion-dollar industry in India
9. The World Bank funds private Hospital in India
10. Parke-Davis (India) runs into rough weather – Court orders attachment of asset
11. Indian Doctor granted US patent on organ regeneration
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... ... , ... 21 Middle East and South Asia Leaders Selected as Eisenhower Fellows ... and civil society in 11 countries across the Middle East and South Asia to ... exchange of knowledge and ideas with the leading minds in their fields. , ...
(Date:6/23/2017)... ... , ... PureLife Dental is pleased to announce that California Dental Association (CDA) ... of the amalgam separator endorsement, all CDA members may purchase an ECO II amalgam ... value. This partnership between PureLife and CDA is especially timely as it coincides with ...
(Date:6/23/2017)... , ... June 23, 2017 , ... American Farmer, will ... series, which is slated to air fourth quarter 2017. American Farmer airs Tuesdays at ... Hansen, a Danish pharmacist, founded Chr. Hansen in Denmark in 1874 after a groundbreaking ...
(Date:6/23/2017)... ... June 23, 2017 , ... ... and related services to families and business owners in and around Lackawanna County, ... benefit senior citizens in the area. , Meals on Wheels of NEPA provides ...
(Date:6/23/2017)... ... June 23, 2017 , ... All-Star Insurance, a family managed agency that ... eastern Texas, is announcing the launch of a new charity drive to benefit women ... the United States reveal that an estimated 252, 710 new cases of invasive or ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... 2017  Less than a month ago, amateur hackers ... companies, including hospital networks, in over 150 countries. ... the largest online extortion attempts ever recorded. With the ... is imperative that providers understand where the risks lie, ... — and many other very real cyber threats.  ...
(Date:6/7/2017)... 7, 2017  Novavax, Inc., (Nasdaq: NVAX ) ... 2 trials of its RSV F protein recombinant nanoparticle vaccine ... have been published in the journal Vaccine ... in prior scientific conferences). The Company previously announced top ... is developing the RSV F Vaccine with the goal of ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
Breaking Medicine Technology: